Key statistics
On Friday, Iovance Biotherapeutics Inc (2LB:MUN) closed at 10.35, -38.47% below its 52-week high of 16.82, set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.38 |
---|---|
High | 10.38 |
Low | 10.35 |
Bid | 9.82 |
Offer | 9.93 |
Previous close | 11.24 |
Average volume | 1.74k |
---|---|
Shares outstanding | 303.51m |
Free float | 274.71m |
P/E (TTM) | -- |
Market cap | 3.21bn USD |
EPS (TTM) | -1.50 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 08:27 GMT.
More ▼
- Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
- Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
- Iovance Biotherapeutics to Present at Upcoming Conferences
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
- Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024
- Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
- Iovance Biotherapeutics to Present at Upcoming Conferences and Events
- Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
- Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
More ▼